Lai C Kc, Wong S Yn, Lee S Sy, Siu H K, Chiu C Y, Tsang D Nc, Ip M Py, Hung C T
Department of Pathology, Queen Elizabeth Hospital, Hong Kong.
Infection Control Team, Queen Elizabeth Hospital, Hong Kong.
Hong Kong Med J. 2017 Apr;23(2):140-9. doi: 10.12809/hkmj164939. Epub 2017 Feb 24.
Apart from individual small-scale outbreaks, infections with vancomycin-resistant enterococci are uncommon in Hong Kong. A major outbreak of vancomycin-resistant enterococci, however, occurred at a large tertiary hospital in 2013. We describe the successful control of this outbreak and share the lessons learned.
In 2013, there was an abnormal increase in the incidence of vancomycin-resistant enterococci carriage compared with baseline in multiple clinical departments at Queen Elizabeth Hospital. A multipronged approach was adopted that included a 10-week hospital-wide active screening programme, which aimed to identify and isolate hidden vancomycin-resistant enterococci carriers among all in-patients. The identified carriers were completely segregated in designated wards where applicable. Other critical infection control measures included directly observed hand hygiene and environmental hygiene. A transparent and open disclosure approach was adopted throughout the outbreak.
The infection control measures were successfully implemented. The active screening of vancomycin-resistant enterococci was conducted between 30 September and 10 November 2013. A total of 7053 rectal swabs were collected from patients in 46 hospital wards from 11 departments. The overall carriage rate of vancomycin-resistant enterococci was 2.8% (201/7053). Pulsed-field gel electrophoresis showed a predominant outbreak clone. We curbed the outbreak and kept the colonisation of vancomycin-resistant enterococci among patients at a pre-upsurge low level.
We report the largest cohesive effort to control spread of vancomycin-resistant enterococci in Hong Kong. Coupled with other infection control measures, we successfully controlled vancomycin-resistant enterococci to the pre-outbreak level. We have demonstrated that the monumental tasks can be achieved with meticulous planning, and thorough communication and understanding between all stakeholders.
除个别小规模疫情外,耐万古霉素肠球菌感染在香港并不常见。然而,2013年一家大型三级医院发生了耐万古霉素肠球菌的重大疫情。我们描述了此次疫情的成功控制情况,并分享了经验教训。
2013年,伊丽莎白女王医院多个临床科室耐万古霉素肠球菌携带率较基线出现异常增加。采取了多管齐下的方法,包括一项为期10周的全院主动筛查计划,旨在识别并隔离所有住院患者中隐藏的耐万古霉素肠球菌携带者。对识别出的携带者,在适用的情况下将其完全隔离在指定病房。其他关键的感染控制措施包括直接监督手部卫生和环境卫生。在整个疫情期间采用了透明公开的信息披露方法。
感染控制措施成功实施。2013年9月30日至11月10日期间对耐万古霉素肠球菌进行了主动筛查。共从11个科室的46个医院病房的患者中采集了7053份直肠拭子。耐万古霉素肠球菌的总体携带率为2.8%(201/7053)。脉冲场凝胶电泳显示有一个主要的疫情克隆株。我们遏制了疫情,并将患者中耐万古霉素肠球菌的定植维持在疫情爆发前的低水平。
我们报告了香港为控制耐万古霉素肠球菌传播所做的最大规模协同努力。结合其他感染控制措施,我们成功地将耐万古霉素肠球菌控制在疫情爆发前的水平。我们证明,通过精心规划以及所有利益相关者之间的充分沟通与理解,可以完成这项艰巨任务。